Company Announcements New England Biolabs (NEB) agreed in October 2011 to distribute the Single Cell Whole Genome Amplification Kit, which uses Rubicon Genomics’ amplification technology. This is the first NEB product targeted at the single-cell amplification market. WaferGen Biosystems CEO and President Alnoor Shivji resigned in October 2011 but remains chairman. An Office of the […]

Company Announcements DNAnexus secured $15 million in October 2011 in second round funding led by Google Ventures and TPG Biotech. The company also entered into a technology collaboration with Google to provide an archive of publicly available DNA data through a Sequence Read Archive site hosted by Google Cloud Storage. Elsevier and PerkinElmer in November […]

Company Announcements ArcticZymes signed a new supply agreement with Affymetrix for its Shrimp Alkaline Phosphatase enzyme covering September 2011 through December 2017. Affymetrix previously held exclusive distribution rights. GE Healthcare Life Sciences exclusively licensed the patent and know-how from Affitech in October 2011 for products containing recombinant Protein L. EMD Millipore will be the initial […]

Company Announcements In November 2011, Shimadzu signed a memorandum of understanding with Singapore’s Nanyang Polytechnic to set up a Center of Excellence in Food Safety & Laboratory Analytical Methods. Agilent in November 2011 joined the sponsors of GreenCentre Canada, a national center of excellence for commercializing green chemistry discovery generated by academic researchers and industry. […]

Five new Excellence Initiatives (Idex) recipients were announced earlier this month as part of France’s €35 billion ($46.2 billion) Investments for the Future stimulus package, which includes €21.9 billion for R&D and universities. The five universities—Aix-Marseille, Toulouse, Paris-Saclay, Sorbonne Université and Sorbonne Paris Cité—join the previous Idex selections: Strasbourg, Idex Bordeaux and Paris Sciences et […]

China’s State Council has announced a four-year plan to increase drug standards to meet international levels. The new standards would cover 6,500 drugs, including 2,800 drugs based on traditional Chinese medicines. Also included would be 2,500 chemical-based drugs and 200 biologic drugs. However, the priority would be drugs listed in the country’s catalog of essential […]

On February 9, the FDA released its guidelines on biosimilars, which propose an “abbreviated pathway” for approval that would vary by product. The biosimilar must be shown to be “highly similar” to the original. The requirements for clinical and animal studies would depend on an evaluation of analytical data, as well as scientific and manufacturing […]

The Obama administration announced this month $80 million in new funding for Alzheimer’s disease research, adding to the $450 million the NIH currently spends. The NIH will receive $50 million in reallocated money for fiscal 2012, half of which will go to sequencing centers funded by the National Human Genome Research Institute to sequence the […]

The number of hectares of biotech crops increased 8% in 2011 to 160 million. Twenty-nine countries grew biotech crops last year, led by the US (43% of total hectares), Brazil (19%) and Argentina (15%). Twelve countries planted stacked-trait crops, which accounted for 42.2 million hectares. Brazil was the country whose hectarage of biotech crops grew […]

Private R&D spending on agricultural inputs grew 4.4% from 2009 to 2010, according to the US Department of Agriculture Economic Research Service’s December 2011 report entitled Research Investments and Market Structure in the Food Processing, Agricultural Input and Biofuel Industries Worldwide. The report analyzes worldwide private R&D spending for seven agricultural-input areas, as well as […]